(Times of Israel) Judah Ari Gross - The Israel Defense Ministry's Institute for Biological Research has found two drugs used to treat the genetic disorder known as Gaucher's disease are also effective against the coronavirus and potentially other viruses as well, the laboratory announced Tuesday. Since Cerdelga has already been approved for use by the U.S. FDA and Venglustat has almost completed the approval process, they may be fast-tracked for use with Covid-19 patients, the Defense Ministry said. A study on mice found that the medications inhibited the replication of the coronavirus, and were also found to work against Neuroinvasive Sindbis virus, West Nile virus and Influenza A virus.
2020-05-27 00:00:00Full ArticleBACK Visit the Daily Alert Archive